Silver Lake Research Corporation dba Silverlake Research
- View government funding actions
- Monrovia, CA 910168403
- Phone: 626-359-8441
- Corporate URL: www.silverlakeresearch.com
- Estimated Number of Employees: 20
- Estimated Annual Receipts: $1,500,000
- Business Start Date: 1992
- Contact Person: Mark Geisberg
- Contact Phone: 626-359-8441
- Contact Email: mgeisberg@silverlakeresearch.com
- Business Structure:
- Corporate Entity (Not Tax Exempt)
- Business Type:
- For Profit Organization
- Manufacturer of Goods
- Industries Served: Pharmaceutical Preparation Manufacturing, In-Vitro Diagnostic Substance Manufacturing, All Other Miscellaneous Chemical Product and Preparation Manufacturing, Other Professional Equipment and Supplies Merchant Wholesalers, Drugs and Druggists' Sundries Merchant Wholesalers
- Product Areas: R&D- AGRICULTURE: OTHER (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), R&D-OTHER AGRI-A RES/EXPL DEV, SERVICES (BASIC), R&D- DEFENSE OTHER: SERVICES (BASIC RESEARCH), SERVICES (APPLIED/EXPLORATORY), R&D- DEFENSE OTHER: SERVICES (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), LIFE SCIENCES (BASIC), R&D- GENERAL SCIENCE/TECHNOLOGY: LIFE SCIENCES (BASIC RESEARCH), R&D- MEDICAL: BIOMEDICAL (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), BIOMEDICAL (APPLIED/EXPLORATORY), BIOMEDICAL (ADVANCED), R&D- MEDICAL: BIOMEDICAL (ADVANCED DEVELOPMENT), R&D- MEDICAL: BIOMEDICAL (COMMERCIALIZED), R&D-BIOMEDICAL-COMERCLIZ
Sampling of Federal Government Funding Actions/Set Asides
In order by amount of set aside monies.
- $204,890 - Friday the 24th of August 2012
Office Of Procurement Operations
SCIENCE AND TECHNOLOGY ACQUISITION DIVISION
DIVISION: CHEMICAL&BIOLOGICAL PPA: CBRNE DEFENSE R&D PROGRAM: BIOAGENT DETECTION PROJECT: BIOASSAYS - NEAR TERM PERFORMER: SILVER LAKE RESEARCH CORPORATION APPROPRIATION YEAR: FY12 (24 FUNDS) BUDGET AUTHORITY: THREE YEAR R&D FUNDS PROJECT MANAGER: DAVID HODGE, 202-254-5813 LEAD SUPPORT STAFF: JASON RAMAGE, 202-254-6799 ALC: 70-08-1513 TAS: 70240800 DESCRIPTION: THE PURPOSE OF THIS PR IS TO FUND SILVER LAKE RESEARCH CORPORATION, A PERFORMER SELECTED UNDER THE LONG RANGE BROAD AGENCY ANNOUNCEMENT 11-03, IN THE AMOUNT OF $206,015. SILVER LAKE RESEARCH CORPORATION WILL AID THE NEXT GENERATION PROJECT IN ITS EFFORTS TO IMPROVE THE ABILITY TO IDENTIFY AND CHARACTERIZE BIOTHREAT AGENTS. SILVER LAKE RESEARCH CORPORATION WILL COMBINE THE STRONGEST FEATURES OF BOTH GENOMIC AND IMMUNOLOGICAL APPROACHES TO PATHOGEN DETECTION, AND WILL USE ITS PROPRIETARY EAP IMMUNIZATION TO 1) OVERCOME THE PROBABLE "NON-IMMUNOGENICITY" OF SELECTED SEQUENCES, AND 2) ENSURE THAT THE ANTIBODIES ARE DESIGNED TO BIND TO THE SELECTED SEQUENCE IN THE CONTEXT OF THE INTACT NATIVE PROTEIN. DHS TECHNICAL POINT OF CONTACT: DAVID R. HODGE, PH.D. PROGRAM MANAGER, CBD R&D DEPARTMENT OF HOMELAND SECURITY SCIENCE AND TECHNOLOGY DIRECTORATE CHEMICAL AND BIOLOGICAL DEFENSE DIVISION U.S. DEPARTMENT OF HOMELAND SECURITY WASHINGTON, DC 20528 PHONE: 202-254-5813 EMAIL: DAVID.HODGE@DHS.GOV ACCS:
© Copyright 2019
The Collier Report published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources.
No reliance should be made by readers or Collier Report subscribers.
Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances.
Requests for the modification of displayed information may be made to help.desk@1918.media.